# A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

> **NCT01243671** · PHASE3 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 20 (actual)

## Conditions studied

- Intestinal Behçet's Disease

## Interventions

- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT01243671
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-03
- **Final completion:** 2013-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243671, "A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01243671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*